Treatment options for patients with severe gastroparesis.
Abrahamsson
Hasse
H
Department of Internal Medicine, Sahlgrenska University Hospital, S-413 45 Göteborg, Sweden. hasse.abrahamsson@medic.gu.se
D001905:Botulinum Toxins / Q000627:therapeutic use; D018492:Dopamine Antagonists / Q000627:therapeutic use; D004599:Electric Stimulation Therapy / Q000379:methods; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D018589:Gastroparesis / Q000188:drug therapy / Q000628:therapy*; D006801:Humans; D018942:Macrolides / Q000627:therapeutic use
D018492:Dopamine Antagonists; D005765:Gastrointestinal Agents; D018942:Macrolides; D001905:Botulinum Toxins